<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04003558</url>
  </required_header>
  <id_info>
    <org_study_id>SYSEC-KY-KS-2019-054-001</org_study_id>
    <nct_id>NCT04003558</nct_id>
  </id_info>
  <brief_title>Deep Learning Algorithms for Prediction of Lymph Node Metastasis and Prognosis in Breast Cancer MRI Radiomics (RBC-01)</brief_title>
  <official_title>Deep Learning Algorithms for Prediction of Lymph Node Metastasis and Prognosis in Breast Cancer MRI Radiomics (RBC-01)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sun Yat-sen University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tungwah Hospital of Sun Yat-Sen University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shunde Hospital of Southern Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Zhongshan Ophthalmic Center, Sun Yat-sen University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This bi-directional, multicentre study aims to assess multiparametric MRI Radiomics-based
      prediction model for identifying metastasis lymph nodes and prognostic prediction in breast
      cancer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Sensitivity for prediction of lymph node metastasis and survival of currently available
      prognostic scores in limited. This study proposes to establish a deep learning algorithms of
      multiparametric MRI radiomics and nomogram for identifying lymph node metastasis and
      prognostic prediction of breast cancer. The study will investigate the relationship between
      the radiomics and the tumor microenvironment. The study includes the construction of
      multiparametric MRI radiomics-based prediction model and the validation of the prediction
      model.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 28, 2019</start_date>
  <completion_date type="Anticipated">January 1, 2025</completion_date>
  <primary_completion_date type="Anticipated">May 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Disease free survival (DFS)</measure>
    <time_frame>5 years</time_frame>
    <description>Disease free survival (DFS), which defined as the time from the diagnosis of breast cancer to the confirmed time of metastatic disease, or death due to any other cause.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The correlation of radiomics features and tumor microenvironment</measure>
    <time_frame>baseline (Completed MRI data before biopsy,surgery,neoadjuvant and radiotherapy.)</time_frame>
    <description>Radiomics is a tool to analyze tumor microenvironment characteristics based on breast MRI images.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lymph node metastasis</measure>
    <time_frame>Baseline</time_frame>
    <description>The value of Radiomics of multiparametric MRI in predicting axillary lymph node metastasis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall survival (OS)</measure>
    <time_frame>5 years</time_frame>
    <description>The association between Radiomics of multiparametric MRI and overall survival (OS), which defined as the time from the beginning of diagnosis of breast cancer to the death with any causes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Beast cancer specific motality (BCSM)</measure>
    <time_frame>5 years</time_frame>
    <description>Defined as time between randomization and the time of death occur specific due to breast cancer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recurrence free survival (RFS)</measure>
    <time_frame>5 years</time_frame>
    <description>defined as time between randomization and the time of any recurrence of ipsilateral chest, breast, regional lymph node recurrence, distant metastases, or death occurred</description>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">1500</enrollment>
  <condition>Breast Neoplasm Female</condition>
  <condition>Early-stage Breast Cancer</condition>
  <condition>Radiomics</condition>
  <condition>Axillary Lymph Node</condition>
  <condition>Survival, Prosthesis</condition>
  <arm_group>
    <arm_group_label>Sun Yat-Sen Memorial Hospital of Sun Yat-sen University</arm_group_label>
    <description>The cohort of Sun Yat-Sen Memorial Hospital of Sun Yat-sen University is a training cohort.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sun Yat-sen University Cancer Center</arm_group_label>
    <description>The cohort of Sun Yat-sen University Cancer Center is a validation cohort.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tungwah Hospital of Sun Yat-Sen University</arm_group_label>
    <description>The cohort of Tungwah Hospital of Sun Yat-Sen University is a validation cohort.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Shunde hospital of southern medical university</arm_group_label>
    <description>The cohort of Shunde hospital of southern medical university is a validation cohort.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No interventions</intervention_name>
    <description>As this is a patient registry, there are no interventions.</description>
    <arm_group_label>Shunde hospital of southern medical university</arm_group_label>
    <arm_group_label>Sun Yat-Sen Memorial Hospital of Sun Yat-sen University</arm_group_label>
    <arm_group_label>Sun Yat-sen University Cancer Center</arm_group_label>
    <arm_group_label>Tungwah Hospital of Sun Yat-Sen University</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who had early stage breast cancer and completed the breast MRI examination before
        operation,lymph node biopsy,neoadjuvant chemotherapy,and radiotherapy.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The primary lesion was diagnosed as invasive breast cancer

          -  Patients can have regional lymph node metastasis,but no distant organ metastasis

          -  Complete the breast MRI examination before treatment

          -  Accept breast cancer surgery or lymph node biopsy

          -  Eastern Cooperative Oncology Group performance status 0-2

        Exclusion Criteria:

          -  Inflammatory breast cancer

          -  Accompanied with other primary malignant tumors

          -  Perform surgery,radiotherapy and lymph node biopsy before breast MRI examination

          -  Patients who have neoadjuvant chemotherapy

          -  Patients had distant and contralateral axillary lymph node metastasis

          -  The pathologic diagnosis was extensive ductal carcinoma in situ
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Herui Yao, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Chuanmiao Xie, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sun Yat-sen University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jie Ouyang, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tungwah Hospital of Sun Yat-Sen University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Qiugen Hu, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shunde Hospital of Southern Medical University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Haotian Lin, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Zhongshan Ophthalmic Center, Sun Yat-sen University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Herui Yao, PhD</last_name>
    <phone>+8613500018020</phone>
    <email>yaoherui@mail.sysu.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yunfang Yu, MD</last_name>
    <phone>+8613660238987</phone>
    <email>yuyf9@mail.sysu.edu.cn</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Tungwah Hospital of Sun Yat-Sen University</name>
      <address>
        <city>Dongguan</city>
        <state>Guangdong</state>
        <zip>523000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jie Ouyang, PhD</last_name>
      <phone>+8613537479470</phone>
      <email>kitty865@163.com</email>
    </contact>
    <investigator>
      <last_name>Jie Ouyang, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shunde hospital of southern medical university</name>
      <address>
        <city>Foshan</city>
        <state>Guangdong</state>
        <zip>528300</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Qiugen Hu, PhD</last_name>
      <phone>+8613928206009</phone>
      <email>hu6009@163.com</email>
    </contact>
    <investigator>
      <last_name>Qiugen Hu, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Xiaohong Li, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sun Yat-sen University Cancer Center</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Chuanmiao Xie, PhD</last_name>
      <phone>+8618903050011</phone>
      <email>xiechm@sysucc.org.cn</email>
    </contact>
    <investigator>
      <last_name>Chuanmiao Xie, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nian Lu, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Zhongshan Ophthalmic Center, Sun Yat-Sen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Haotian Lin, PhD</last_name>
      <phone>+8613802793086</phone>
      <email>gddlht@aliyun.com</email>
    </contact>
    <contact_backup>
      <last_name>Wenben Chen, MD</last_name>
      <phone>+8618819472798</phone>
      <email>Weberchan@foxmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Haotian Lin, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Wenben Chen, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sun Yat-Sen Memorial Hospital of Sun Yat-sen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510120</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Herui Yao, PhD</last_name>
      <phone>+8613500018020</phone>
      <email>yaoherui@mail.sysu.edu.cn</email>
    </contact>
    <investigator>
      <last_name>Herui Yao, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yufang Yu, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yujie Tan, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kai Chen, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>June 26, 2019</study_first_submitted>
  <study_first_submitted_qc>June 28, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 1, 2019</study_first_posted>
  <last_update_submitted>August 13, 2019</last_update_submitted>
  <last_update_submitted_qc>August 13, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 15, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University</investigator_affiliation>
    <investigator_full_name>Herui Yao</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Early-stage Breast Cancer</keyword>
  <keyword>Radiomics</keyword>
  <keyword>Axillary lymph node metastasis</keyword>
  <keyword>Tumor microenvironment</keyword>
  <keyword>Survival</keyword>
  <keyword>Deep learning</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
    <mesh_term>Neoplasm Metastasis</mesh_term>
    <mesh_term>Prosthesis Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Requests for the individual data or study documents will be considered where the proposed use aligns with public good purposes, does not conflict with other requests, and the requestor is willing to sign a data access agreement. Contact is though the corresponding author.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

